The outbreak of the rapidly spreading COVID-19 infection in December 2019 became a catalyst for significant transformations within the global healthcare system. This necessitated the reorganisation of specialised services to utilise available resources more effectively and to safeguard the safety of patients and medical staff. The diagnosis and treatment of cancer are processes that cannot be delayed, as doing so may result in irreversible detrimental outcomes. In light of this, oncology organisations, amidst complete uncertainty, advocated for the persistent treatment of cancer throughout this crisis with utmost diligence. The COVID-19 pandemic compelled oncologists to overhaul aspects of medical care at every stage, impacting all involved in the process. The aim of this article is to analyse and assess the methods of organising oncological care under pandemic conditions, including an examination of the safety measures and treatment method adaptations already implemented amidst total uncertainty. As the pandemic rapidly evolves, it will require constant updating and reforming of strategies and guidelines to ensure safe and high-quality medical care.

oncology, cancer, pandemic, infection control, chemotherapy, telemedicine, patient safety.